Global Bioabsorbable Ureteral Stent Market Size By Type (Plastic Stents, Metal Stents), By Application (Hospital, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Bioabsorbable Ureteral Stent Market was valued at USD 180 million in 2023 and is projected to reach USD 385 million by 2031, growing at a CAGR of 9.9% during the forecast period from 2023 to 2031. This market is gaining momentum due to the rising demand for advanced urological treatments that minimize patient discomfort and eliminate the need for secondary removal procedures. Bioabsorbable ureteral stents are designed to degrade naturally within the body, offering a safer and more convenient alternative to traditional polymeric stents.

The increasing prevalence of urological disorders, advancements in biomaterials, and the growing inclination towards minimally invasive surgeries are driving the demand. Additionally, rising awareness among urologists and healthcare providers regarding the clinical benefits of bioabsorbable stents is boosting market growth.

Drivers:

1. Increasing Incidence of Urological Disorders:

Conditions such as kidney stones, ureteral strictures, and tumors necessitate the use of stents. The global rise in these conditions is directly contributing to market growth.

2. Advancements in Bioabsorbable Materials:

Technological innovations in biodegradable polymers are enhancing the performance and safety profile of bioabsorbable ureteral stents, encouraging broader adoption.

3. Preference for Non-Invasive & Patient-Friendly Solutions:

Bioabsorbable stents eliminate the need for a second procedure for stent removal, significantly improving patient comfort and reducing healthcare costs.

Restraints:

1. High Product Costs:

Bioabsorbable stents are relatively more expensive than conventional options, which may limit adoption, especially in cost-sensitive regions.

2. Limited Clinical Evidence & Reimbursement Challenges:

While promising, these stents still face challenges in large-scale clinical validation and lack of widespread insurance coverage in some regions.

Opportunity:

1. Growth in Emerging Economies:

Improving healthcare infrastructure and increasing investments in urology care in Asia-Pacific and Latin America present strong growth opportunities.

2. Strategic Collaborations and R&D Investments:

Partnerships between medical device companies and research institutions are fostering innovations in stent design and expanding clinical applications.

Market by System Type Insights:

Based on system type, polymeric bioabsorbable stents dominated the market in 2023 due to their biocompatibility and controlled degradation properties. However, metal-based bioabsorbable stents are emerging rapidly with promising strength and performance advantages in complex urological procedures.

Market by End-use Insights:

Hospitals remained the largest end-use segment in 2023, driven by a high volume of inpatient procedures and adoption of cutting-edge urological devices. The ambulatory surgical centers (ASCs) segment is anticipated to witness significant growth due to the increasing number of outpatient urological interventions.

Market by Regional Insights:

North America accounted for the largest market share in 2023, supported by a high prevalence of urological disorders, advanced healthcare infrastructure, and early adoption of innovative devices. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth due to increasing healthcare awareness, improving access to medical technologies, and expanding medical tourism in countries like India and Thailand.

Competitive Scenario:

Key players in the Global Bioabsorbable Ureteral Stent Market include Boston Scientific Corporation, Coloplast A/S, B. Braun Melsungen AG, Teleflex Incorporated, Allium Medical, and Pnn Medical A/S. These companies are focusing on FDA approvals, product innovations, and expanding their presence in emerging markets. For instance:

In 2023, Boston Scientific launched a next-generation bioabsorbable ureteral stent with enhanced hydrophilic coating for improved placement.

In 2024, Coloplast collaborated with European urology centers for post-market clinical trials to assess long-term outcomes.

In 2025, Teleflex announced a new pipeline of bioabsorbable polymers designed specifically for soft-tissue applications in the urinary tract.

Scope of Work – Global Bioabsorbable Ureteral Stent Market

Report Metric Details

Market Size (2023) USD 180 million

Projected Market Size (2031) USD 385 million

CAGR (2023-2031) 9.9%

Market Segments By System Type (Polymeric, Metal-based), End-use (Hospitals, ASCs), Region

Growth Drivers Increasing urological disorders, advancement in biomaterials, preference for minimally invasive procedures

Opportunities Expansion in emerging markets, R&D-driven product development

Key Market Developments:

2023: Boston Scientific introduced a bioabsorbable ureteral stent with improved degradation timelines, aimed at reducing post-surgical complications.

2024: Coloplast began multi-center trials in Europe assessing patient satisfaction and outcomes with bioabsorbable stents.

2025: Teleflex Incorporated revealed a strategic R&D collaboration to design hybrid metal-polymer bioabsorbable stents for complex urological cases.

FAQs:

1. What is the current market size of the Global Bioabsorbable Ureteral Stent Market?

The market was valued at USD 180 million in 2023.

2. What is the major growth driver of the Global Bioabsorbable Ureteral Stent Market?

The major growth driver is the rising incidence of urological conditions and demand for minimally invasive, patient-friendly stenting solutions.

3. Which is the largest region during the forecast period in the Global Bioabsorbable Ureteral Stent Market?

North America is the largest region, supported by advanced healthcare facilities and high adoption of innovative urological devices.

4. Which segment accounted for the largest market share in the Global Bioabsorbable Ureteral Stent Market?

The polymeric bioabsorbable stent segment held the largest share in 2023.

5. Who are the key market players in the Global Bioabsorbable Ureteral Stent Market?

Key players include Boston Scientific Corporation, Coloplast A/S, B. Braun Melsungen AG, Teleflex Incorporated, Allium Medical, and Pnn Medical A/S.